Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes

Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes

(2017) Alfredo Leaños-Miranda et al.   MEDICINE

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

(2016) Harald Zeisler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia

(2014) Luiza O. Perucci et al.   PLoS One

Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With Preeclampsia

(2013) Alfredo Leaños-Miranda et al.   HYPERTENSION

Hypertension in Pregnancy

(2013)   OBSTETRICS AND GYNECOLOGY

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia

(2012) Alfredo Leaños-Miranda et al.   JOURNAL OF HYPERTENSION

Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia

(2012) Sarosh Rana et al.   PLoS One

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

(2009) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine